This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cambrex Corp (CBM)

NYSE: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 374.61M 319.53M 279.00M 257.43M
Cost of Sales 226.99M 192.80M 164.24M 158.45M
Gross Operating Profit 147.62M 126.73M 114.77M 98.98M
Selling, General, and Administrative Expenses 52.49M 47.57M 45.25M 39.23M
Research & Development 13.07M 10.39M 9.54M 11.04M
Operating Income before D & A (EBITDA) 82.06M 68.77M 59.97M 48.72M
Depreciation & Amortization 23.83M 22.47M 21.77M 23.12M
Interest Income 2.17M 0.00 0.00 2.37M
Other Income - Net -20.76M 3.21M -2.62M -9.65M
Special Income / Charges 1.23M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 45.51M 47.25M 33.81M 19.94M
Interest Expense 0.00 2.24M 2.44M 0.00
Pre-Tax Income 45.51M 45.01M 31.37M 19.94M
Income Taxes -12.63M 14.73M -31.86M 6.20M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 58.13M 30.27M 63.23M 13.73M
Net Income From Discontinued Operations -830.00K -4.36M -926.00K -2.77M
Net Income From Total Operations 57.30M 25.91M 62.30M 10.97M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 57.30M 25.91M 62.30M 10.97M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
56.90M 30.27M 63.23M 13.73M
Preferred Dividends
Net Income Available To Common 58.13M 30.27M 63.23M 13.73M
Basic EPS from Continuing Ops. 1.89 1.00 2.13 0.46
Basic EPS from Discontinued Ops. -0.03 -0.14 -0.03 -0.09
Basic EPS from Total Operations 1.86 0.86 2.10 0.37
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.86 0.86 2.10 0.37
Basic Normalized Net Income/Share 1.85 1.00 2.13 0.46
EPS fr Continuing Ops. 1.84 0.98 2.09 0.46
EPS fr Discontinued Ops -0.03 -0.14 -0.03 -0.09
EPS fr Total Ops. 1.81 0.84 2.06 0.37
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.81 0.84 2.06 0.37
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.80 0.98 2.09 0.46
Dividends Paid per Share 0.00 0.00 0.00 0.00
CBM News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CBM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CBM ANALYST REPORT

CBM Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs